C60 including Hansen solubility parameters, modeling,,, and artificial intelligence without success.

Fuller Research has developed a process using components of essential oils to fully dissolve C60 crystals into free bioactive molecules at a concentration of 16.7 mg/ml, which is twenty times what can be achieved in olive oil and is sufficient for developing functional applications. We confirmed full dissolution via Transmission Electron Microscopy performed by NUANCE TEM at Northweern University. The process was awarded US Patent 11,484,508 Dissolved C60 and Method of Producing Dissolved C60 on November 1, 2022.

We have used solubilized C60 to produce a convenient gum-based strip that delivers 100 µg per strip. One or two strips a day is the suggested intake. This product was awarded US Patent 10,842,742 on November 24, 2020.

We have also developed a nebulizable liquid that delivers 50 µg of solubilized per ml directly into the lungs. This product was awarded US Patent 11,400,113 on August 2, 2022. We expect that delivering a powerful antioxidant to infected lung tissue will mute the Cytokine Storm that can result from COVID and Flu infections and present an opportunity to develop a new class of treatment that can act synergistically with current medications.